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ABSTRACT  Metabotropic glutamate receptors (mGluRs) include receptors sensi- 
tive  to  L-2-amino-4-phosphonobutyrate (L-AP4)  and  1S,3R-l-aminocyclopentane- 
1,3-dicarboxylic  acid  (1S,3R-ACPD).  To  determine  whether  1S,3R-ACPD  is  an 
agonist  at  retinal  L-AP4  receptors,  whole  cell  voltage  clamp  recordings  were 
obtained from mudpuppy ON bipolar cells in a superfused retinal slice and L-AP4 
and  1S,3R-ACPD  were  bath  applied.  Both  compounds  evoked  similar  outward 
currents which reversed near 0  mV and were accompanied by an increased input 
resistance.  Responses to both agonists washed out in parallel suggesting they act 
through  the  same second messenger pathway(s). Inhibitors of cGMP-PDE activity 
suppressed  responses  to  both  L-AP4  and  1SR,3RS-ACPD,  suggesting  that  both 
compounds activate cGMP-PDE. Responses to 1S,3R-ACPD  were occluded by prior 
activation of L-AP4 receptors, but not blocked by the non-AP4, mGluR antagonists, 
L-aminophosphonopropionic  acid  (L-AP3)  or  4-carboxy-3-hydroxyphenylglycine 
(4C3H-PG).  These  results  indicate  that  1S,3R-ACPD  is  an  agonist  at  L-AP4 
receptors.  1S,3S-ACPD  and  4C3H-PG evoked outward  currents  similar to  L-AP4 
suggesting they may also be L-AP4 receptor agonists. Using the b-wave of the ERG 
as  an  assay  for  ON  bipolar  cell  responses,  concentration/response  curves were 
obtained for ACPD enantiomers. The rank-order potency of ACPD enantiomers at 
L-AP4  receptors  in  ON  bipolar  cells  is  similar  to  their  rank-order  potency  at 
non-AP4, mGluRs in brain which suggests that the receptors possess similar binding 
sites and may be members of a common receptor family. 
INTRODUCTION 
The amino acid,  L-glutamate, is the major excitatory neurotransmitter in the brain, 
spinal cord, and retina. The effects of glutamate are mediated by two general classes 
of receptors: (a) ionotropic receptors which are coupled directly to ion channels and 
include N-methyl-D-aspartate (NMDA), ot-amino-3-hydroxy-5-methylisoxazole-4-pro- 
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pionic acid (AMPA) and kainic acid (KA) receptors (for reviews see Collingridge and 
Lester,  1989; Monaghan, Bridges,  and  Cotman,  1989; and Watkins,  Krogsgaard- 
Larsen,  and  Honor6,  1990) and  (b)  metabotropic  glutamate  receptors  (mGluRs) 
which are coupled to G-proteins and act through intracellular second messengers (for 
review see Schoepp and Conn, 1993). 
ON depolarizing bipolar cells of the vertebrate retina possess receptors sensitive to 
micromolar concentrations of L-2-amino-4-phosphonobutyric acid (L-AP4) (Shiells, 
Falk, and Naghshineh, 1981; Slaughter and Miller,  1981). L-AP4 receptors are also 
found in other regions of the central nervous system, including the hippocampus, 
spinal cord,  and olfactory bulb  (Koerner and Cotman,  1981; Davies and Watkins, 
1982;  Trombley  and  Westbrook,  1992). For  many years,  both  the  transduction 
mechanisms employed by L-AP4 receptors and the relationship of L-AP4 receptors to 
other  glutamate  receptors  were  unknown.  However,  as  discussed  below,  recent 
studies have begun to clarify these issues. 
The transduction mechanisms employed by L-AP4 receptors have been studied in 
some detail in both retinal ON bipolar cells and olfactory bulb neurons. In both cell 
types,  L-AP4 receptors  are  coupled  to  G-proteins.  In  retinal  ON  bipolar  cells, 
activation of the G-protein stimulates cGMP-phosphodiesterase (cGMP-PDE) activity 
resulting in the closing of cGMP-sensitive cation channels, similar to phototransduc- 
tion (Nawy and Jahr, 1990, 1991; Shiells and Falk,  1990). In olfactory bulb neurons, 
G-protein  activation by  L-AP4 receptors  results  in  the  inhibition of Ca  currents 
(Trombley and Westbrook,  1992). 
The relationship of L-AP4 receptors to other glutamate receptors is also becoming 
clear.  A  family of mGluRs  has  been  cloned  and  sequenced  (Houamed,  Kuijper, 
Gilbert,  Haldeman, O'Hara,  Mulvihill, Almers,  and  Hagen,  1991; Masu,  Tanabe, 
Tsuchida, Shigemoto, and  Nakanishi,  1991; Tanabe,  Masu,  Ishii,  Shigemoto, and 
Nakanishi, 1992; Tanabe, Nomura, Masu, Shigemoto, Mizuno, and Nakanishi, 1993; 
Abe,  Sugihara,  Mizuno,  and  Nakanishi,  1992; Nakanishi,  1992; Thomsen,  Kris- 
tensen,  Mulvihill, Haldeman, and Suzdak,  1992; Duvoisin,  1993). One member of 
this family, mGluR4, can be stimulated by micromolar concentrations of L-AP4 and is 
therefore an L-AP4 receptor (Thomsen et al.,  1992; Tanabe et al.,  1993). MGIuR6 
exhibits 70%  sequence homology to mGluR4 and is  selectively localized  in retina 
suggesting that  it  may be  the  L-AP4 receptor  found in  retinal ON  bipolar  cells 
(Nakanishi,  1992; Duvoisin,  1993). In contrast, the subtypes mGluR1-3  and mGluR5 
are relatively insensitive to L-AP4 (Aramori and Nakanishi, 1992; Tanabe et al., 1992, 
1993;  Abe  et  al.,  1992), as  are  many  mGluRs  in  vivo (Schoepp,  Bockaert,  and 
Sladeczek,  1990a). Thus, it appears that L-AP4 receptors are members of a larger 
family of homologous mGluRs. 
The conformationally constrained glutamate analogue, (1S,3R)-l-aminocyclopen- 
tane-l,3-dicarboxylic acid (1S,3R-ACPD), is a selective agonist for mGluRs (Palmer, 
Monaghan, and Cotman,  1989; Desai  and Conn,  1990; Irving,  Schofield,  Watkins, 
Sunter,  and  Collingridge,  1990; Schoepp,  Johnson,  True,  and  Monn,  1991b). 
However, despite the apparent homology among L-AP4-sensitive and L-AP4-insensi- 
tive mGluRs,  it is not clear whether 1S,3R-ACPD is an agonist for L-AP4 receptors. 
1S,3R-ACPD causes  a  weak  and  inconsistent activation of mGluR4  expressed  in 
Chinese hamster ovary cells (Tanabe et al.,  1993). L-AP4 and ACPD produce similar THORESON AND MILLER  1S,3R-ACPD Is an Agonist at Retinal L-AP4 Receptors  1021 
effects  in  retina  (Slaughter  and  Miller,  1985),  hippocampus  (Baskys and  Malenka, 
1991),  and  spinal  cord  (Pook,  Sunter,  Udvarhelyi,  and  Watkins,  1992),  but  it  is 
unclear  from  these  studies  whether  the  two  agonists  act  at  the  same  receptor  or 
activate different receptors whose intracellular second messenger pathways converge. 
The  present  study  assessed  the  similarity  of L-AP4  receptor  binding  sites  to  the 
binding  sites  of  L-AP4-insensitive  mGluRs  by  determining  the  affinity  of L-AP4 
receptors for 1S,3R-ACPD and its enantiomers. 
The  results  indicate  that  1S,3R-ACPD  is  an  agonist  at  L-AP4  receptors.  Thus, 
although  1S,3R-ACPD is selective for mGluRs over ionotropic glutamate receptors, it 
does not select between L-AP4-sensitive and L-AP4-insensitive mGluRs.  In addition, 
the  four  enantiomers  of ACPD  exhibit  a  rank-order  potency  at  retinal  L-AP4 
receptors similar to their rank-order potency at non-AP4 mGluRs in brain suggesting 
that  both  classes  of  receptors  possess  similar  binding  sites.  These  results  are 
consistent with the hypothesis that L-AP4 receptors are members of a larger family of 
mGluRs. 
A  brief abstract  of these  results  has  appeared  previously  (Thoreson  and  Miller, 
1992). 
MATERIALS  AND  METHODS 
Whole Cell Voltage Clamp Recordings 
Whole  cell  patch  clamp  recordings were  obtained  from  ON  bipolar  cells  in  a  superfused 
mudpuppy (Necturus maculosus) retinal slice preparation similar to that developed by Werblin 
(1978) and described in detail by Wu (1987). 
The superfusate contained  111  mM NaCI, 2.5 mM KCI,  1.8 mM CaCI~, 0.5 mM MgC12, 5 
mM glucose, and 10 mM HEPES. For whole cell recordings, COC12 (2-5 mM) was added to the 
superfusate to suppress  synaptic transmission.  The pH was adjusted  to 7.8 with  NaOH and 
bubbled continuously with  100% 02. Experiments were done at room temperature (20-25~ 
Drugs were added to the superfusate and typically applied for 30-45 s. The retina was washed 
with control medium for 3-5 min between drug applications. 
Patch pipettes were fabricated from omega dot borosilicate glass (1.2 mm O.D., 0.95 id) on a 
Narashige PP-83 pipette puller. The tips were  ~ 2 I~m in diameter and had resistances of 4-8 
MI'~. The access resistance was typically less than 50 Mf~ while the input resistance of these cells 
averages  1.5 GO,  so the access  resistance  introduced a voltage clamp error of less  than  3% 
(Thoreson and Miller,  1993). 
The pipettes were filled with (in raM): CsCHsSO4 98, NaCI 3.5, MgCl~ 3, CaCI~ 1, EGTA 11, 
HEPES 5, o-glucose 2, glutathione 1, ATP-Mg 1, GTP 0.5. In some experiments, KCHsSO4 was 
used instead of CsCHsSO4.  Cs was used for all experiments unless stated otherwise, cGMP (1 
mM) was  sometimes added  to the  intracellular  Ringer's solution  (e.g.,  Fig.  2).  The pH was 
adjusted to 7.2 with CsOH or KOH. The electrodes also contained 0.025% 5,6-carboxyfluores- 
cein  or  0.05%  sulfarhodamine  101  to  permit  fluorescent visualization  of the  cell  following 
recording. 
Glutamate agonists were provided byJ. C. Watkins, Tocris Neuramin. Zaprinast was provided 
by Rhrne-Poulenc Rorer. KCHsSO4 was obtained from Pfaltz and Bauer. Fluorescent dyes were 
obtained  from  Molecular  Probes,  Inc.  (Eugene,  OR).  All  other  drugs  and  chemicals  were 
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ON bipolar cells were identified  physiologically by their response to response to L-AP4 (5 
p.M) and morphologically by the presence of a cell body in the distal inner nuclear layer with 
termination of the axon in the proximal inner plexiform layer (sublamina  B). 
ERG Pharmacology 
The b-wave  of the DC-ERG was recorded intraretinatty in  a  superfused mudpuppy eyecup 
preparation  (see  Fig.  6).  A patch pipette  filled with  extracellular medium was used  as  the 
recording electrode. The amplitude of the b-wave was measured from its peak to the trough of 
the  a-wave. The  fraction of the  b-wave  remaining in  the  presence of the  drug  (fractional 
response)  was  plotted  as  a  function  of log  concentration  of the  drug.  The  ICs0's were 
determined  using  a  weighted  algorithm based  on  the  equation:  b/bronx =  [1  +  (c/ICs0)h] -1 
where c =  agonist concentration, ICs0 =  concentration required to produce 50% inhibition of 
the b-wave, h  -- Hill coefficient,  and b/bm,~, -- fractional response of the b-wave. For a more 
complete description of the methods used for recording the ERG and calculating  the ICs0, see 
Peterson, Thoreson, Johnson, Koerner, and Miller, (1991). 
RESULTS 
Whole Cell Voltage Clamp Recordings 
Fig.  1 shows the currents in an ON bipolar cell in the mudpuppy retinal slice evoked 
by  L-AP4  (5  ~M,  Fig.  1A)  and  1S,3R-ACPD  (160  ~M,  Fig.  1C).  At  a  holding 
potential of -50 mV, both compounds evoked virtually identical outward membrane 
currents of ~ 40 pA accompanied by a reduction in membrane noise. At a concentra- 
tion of 160 p.M, the currents evoked by 1S,3R-ACPD averaged 35.7 +  6.6 pA (-SEM, 
n  =  3), while at 80 p,M, the currents averaged 24.0  -  11.3 pA (n =  2). 
Current/voltage  relationships were determined by applying  150  ms voltage steps 
before application of the drug and near the peak of the evoked current (Fig.  1,  A, C, 
and E,  vertical transients). Agonist  current/voltage  relationships  were  calculated  by 
subtracting  the  control  current/voltage  relationships  from  those  obtained  in  the 
presence of the agonist. As shown in the current/voltage plots in Fig.  1, B and D, the 
currents  evoked  by  L-AP4  and  1S,3R-ACPD  both  reversed  near  0  mV  and  were 
accompanied  by  a  negative  slope  conductance.  The  similarities  between  the  re- 
sponses  to  L-AP4 and  1S,3R-ACPD  suggest  that both compounds  act  to close  the 
same species of ion channels,  probably nonspecific cation channels  (Yamashita and 
W~issle,  1991; Thoreson and Miller,  1993). 
Although  less  potent  than  1S,3R-ACPD,  the  1S,3S  enantiomer  of ACPD  also 
evoked an outward current accompanied by a reduction in membrane noise (Fig.  1 E, 
640  I~M). The currents evoked by  1S,3S-ACPD at 640  p.M averaged 28.8  -  4.2  pA 
(n =  4). Like L-AP4 and  1S,3R-ACPD, the currents evoked by 1S,3S-ACPD reversed 
near 0 mV and were accompanied by an increased input resistance (Fig.  1 F). These 
results  suggest  that  1S,3S-ACPD  also  causes  the  closing  of  nonspecific  cation 
channels. 
Like  the  pure  IS,3R enantiomer,  the  racemic mixture  of 1SR,3RS-ACPD  (often 
called  "trans-ACPD";  for  a  discussion  of ACPD  nomenclature  see  Schoepp  et  al., 
1990a)  evoked  outward  currents  similar  to  those  evoked  by  L-AP4  (5  o.M, 
IAP4  =  24.9 -+ 2.6 pA,  n  =  29;  100  p.M,  IACPD =  21.6 --+ 3.6  pA,  n  =  16;  200  ~M, 
IACPD---- 18.7  +  4.1  pA,  n  =  9).  The  pure  1R,3S  enantiomer  had  no  effect  at  a THORESON AND MILLER  IS,3R-ACPD Is an Agonist at Retinal L-AP4 Receptors  1023 
concentration of 1 mM (n =  3). Due to a limited availability of 1S,3R-ACPD, many of 
the following experiments were done using the racemic mixture of 1SR,3RS-ACPD. 
However,  given  the  ineffectiveness of 1R,3S-ACPD,  actions  of  1SR,3RS-ACPD  are 
likely to reflect actions of the  1S,3R enandomer. 
1SR,3RS-ACPD suppresses K channels in hippocampal neurons (Baskys, Bernstein, 
Barolet,  and  Carlin,  1990;  Charpak,  Gahwiler,  Do,  and  Knopfel,  1990).  In  ON 
bipolar  cells,  L-AP4  and  1SR,3RS-ACPD  produced  virtually  identical  responses 
whether the intracellular Ringer's solution contained K (n =  5, data not shown) or Cs, 
which suggests that 1S,3R-ACPD does not act at K channels in these cells. 
The  finding  that  L-AP4  and  1S,3R-ACPD  close  the  same  type  of ion  channel 
suggests  that  either  both  compounds  activate  L-AP4  receptors  or  they  activate 
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FIGURE  1.  Membrane  cur- 
rents of an ON bipolar cell  in 
response  to  L-AP4  (5  ~M;  A 
and B),  1S,3R-ACPD (160  v.M; 
C  and  D),  and  1S,3S-ACPD 
(640  v.M; E  and F).  The cur- 
rents evoked by the agonists at 
a holding potential of -50 mV 
are shown at the left (A, C, and 
E).  Current/voltage  relation- 
ships were  determined  by ap- 
plying  150  ms  voltage  steps 
(vertical transients). The  agonist 
current/voltage  relationships 
shown at the right (B, D, and F) 
were calculated  by subtracting 
the control current/voltage re- 
lationship  from  that  obtained 
in the presence of the agonist. 
separate receptors whose intracellular second messenger cascades converge onto the 
same class of ion  channels.  The  following experiments were undertaken  to  distin- 
guish between these two possibilities. 
In ON bipolar ceils, L-AP4 receptors are coupled to G-proteins which stimulate a 
cGMP-PDE  to  cleave  cGMP,  resulting  in  the  closure  of  cGMP-sensitive,  cation 
channels (Nawy and Jab_r,  1990,  1991; Shiells and Falks,  1990). Despite the presence 
of GTP (0.5 mM), L-AP4-evoked responses steadily diminished during the course of 
our  recordings,  disappearing  altogether  30  min  or  more  into  the  recording.  A 
similar, slow "washout" was also observed when cGMP (1.0 mM) was present in the 
pipette (e.g.,  see Fig.  2). The observation that a  slow washout was observed in both 
the presence and absence of cGMP in the pipette suggests that the washout reflects 1024  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  103  ￿9  1994 
loss of cGMP-PDE activity, rather than saturation of the cation channels by cGMP or 
loss of guanylate cyclase activity. 
Responses to 1SR,3RS-ACPD diminished in parallel with the decrease in amplitude 
of the  responses  to  L-AP4.  This  parallel  washout  is  illustrated  in  Fig.  2.  In  this 
experiment,  L-AP4  (5  ixM)  and  1SR,3RS-ACPD  (200  I~M) were  alternately  bath 
applied. The filled triangles plot the amplitude of the current evoked by L-AP4 (5 
o,M) as a  function of the time of recording.  The solid curve is a  single exponential 
which provided the best fit to the AP4 data. The open triangles plot the amplitude of 
responses to  1SR,3RS-ACPD  (200  I~M). The strong parallel between the washout of 
L-AP4- and ACPD-evoked responses suggests that both agents act through the same 
second messenger cascade. 
Inhibition of cGMP-PDE by dipyridamole suppresses the current evoked by L-AP4 
(Nawy and Jahr,  1991).  Similarly, we found  that  the  cGMP-PDE inhibitors,  dipyri- 
damole (200  ~M, n  =  3)  or zaprinast (100  I~M, n  =  2)  (Gillespie and  Beavo,  1989) 
increased the rate of washout of the L-AP4-evoked current. The filled circles in Fig. 
3 A represent responses to L-AP4 (5 o,M) recorded with zaprinast or dipyridamole in 
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FIGURE 2.  Amplitude  of  the  cur- 
rents  evoked by L-AP4 (5  oLM, filled 
triangles)  and  ISR,3RS-ACPD  (200 
wM, open triangles)  in an ON bipolar 
cell as a function of time of recording. 
The  responses  to  L-AP4 were  fit by 
the  equation  y  =  ae  -b* where  a  = 
26.38 pA and b =  0.02 s (solid curve). 
The  drugs  were  alternately  applied 
for 30--40 s apie~:e. In addition to 0.5 
mM  GTP,  the  patch  pipette  in  this 
experiment contained 1 mM cGMP. 
the  pipette  (n =  5  cells) whereas  the open triangles  represent control responses  to 
L-AP4 recorded without the PDE inhibitors (n =  20 cells). The solid line is the linear 
regression on the cGMP-PDE inhibitor data; the dashed line is the regression on the 
control data. The slope of the cGMP-PDE regression line is significantly steeper than 
the  control  regression  line  (P <  0.05)  indicating  that  the  cGMP-PDE  inhibitors 
diffused into the cells from the pipettes and suppressed responses to L-AP4. 
Fig.  3 B  shows that in  the  presence of zaprinast and  dipyridamole,  responses  to 
1SR,3RS-ACPD (100  ~M) continue to parallel responses to L-AP4. The filled circles 
in Fig.  3 B  represent responses to L-AP4 in the presence of cGMP-PDE inhibitors, 
whereas the open circles represent responses to  1SR,3RS-ACPD  in the  presence of 
these same inhibitors. Note that the concentration of ACPD in Fig. 3, B and C, is 100 
~M, not 200 ~M as used in Fig. 2. The solid line is the linear regression on the L-AP4 
data and the dotted line is the linear regression on the  1SR,3RS-ACPD data. As with 
L-AP4, the slope of the regression line for responses to ACPD in the presence of the 
inhibitors  is  significantly  steeper than  the  control  regression  (dashed  line,  Fig.  3 A; 
P  <  0.05).  In contrast,  the ACPD and AP4  regression lines in  the presence of the THORESON AND MILLER  1S,3R-ACPD Is an Agonist at Retinal L-AP4 Receptors  1025 
inhibitors do  not  differ  significantly. These  results  suggest  that,  like responses  to 
L-AP4,  responses  to  ISR,3RS-ACPD  are  suppressed  by  the  cGMP-PDE  inhibitors, 
zaprinast and dipyridamole. 
ACPD-sensitive mGluRs  can  induce  phosphoinositide  (PI)  hydrolysis (Sladeczek, 
Pin, Recasens, Bockaert, and Weiss, 1985; Sugiyama, Ito, and Hirono,  1987; Schoepp 
and Conn,  1993). An inhibitor of PI hydrolysis, neomycin (100  v~M, n  =  5) (Schacht, 
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FIGURE 3.  (A)  Responses  to  L-AP4 
(5  v.M) recorded with cGMP-PDE in- 
hibitors,  dipyridamole  (200  v.M, 
n =  3  cells)  or  zaprinast  (100  v.M, 
n  =  2  cells),  in  the  pipette  (filled 
circles)  and  control  responses  re- 
corded without cGMP-PDE inhibitors 
(n =  20 cells, open triangles). The solid 
line  is  a  linear  regression  on  the 
cGMP-PDE data, whereas the dashed 
line  is  a  regression  on  the  control 
data.  The  slope  of  the  regression 
line  on  the  cGMP-PDE  data  (b  = 
-0.715  -+  0.200)  is  significantly 
greater (P <  0.05)  than  the slope of 
the control regression (b =  -0.328  _+ 
0.061).  (B)  Responses  to  L-AP4  (5 
v.M, filled  circles,  same  data as in A) 
and  ISR,3RS-ACPD  (100  ~M,  open 
circles)  in the presence of dipyridam- 
ole and zaprinast. Regression lines on 
responses  to  L-AP4  (solid  line)  and 
ACPD  (dotted  line;  b  =  -1.016  -+ 
0.280)  do  not  differ  significantly in 
slope. (C) Responses to L-AP4 (filled 
circles),  ISR,3RS-ACPD (100 IxM, open 
circles), and 1S,3R-ACPD (80 wM, open 
squares)  in the presence of a PI hydro- 
lysis  inhibitor,  neomycin  (100  t~M, 
n  =  5  cells). Regression lines on  re- 
sponses  to  L-AP4  (solid  line;  b  = 
-0.500  -+ 0.489) and  1SR,3RS-ACPD 
(dotted  line;  b =  -0.352 -+ 0.449)  do 
not differ significantly in slope. 
1976; Wang, Wiener, Takada, and Schacht,  1984), did not appear to affect the rate of 
washout  of either  L-AP4  or ACPD-evoked  responses  (Fig.  3 C).  The  absence  of a 
selective suppression  of responses  to ACPD  by  neomycin  suggests  that  the  ACPD 
responses are not mediated by an mGluR coupled to PI hydrolysis and is consistent 
with  the  hypothesis  that  the effects of ACPD  are  mediated by its actions  at  L-AP4 
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If L-AP4 and  ACPD  activate  different  receptors,  messengers,  and  ion  channels, 
currents  evoked  by the  two agents  should  add  linearly under voltage damp  condi- 
tions.  Conversely, if the two activate the  same receptors,  second messengers,  or ion 
channels,  nonadditive  interactions  should occur. We found that strong activation of 
L-AP4 receptors occluded the current evoked by  1SR,3RS-ACPD. Fig. 4 A  shows an 
outward current of 60 pA evoked by a near saturating concentration of L-AP4 (5 ~M). 
Saturation  of the  response  to L-AP4 could reflect  saturation  either  of the  receptor 
A  D  100 pM ACPD 
5 #M L-AP4  L-AP3  4C3H-PG 
200 gM ACPD  2-"'-- 
B 100gMACPD 
20 pAL 
20 s  E  4C3H-PG 
200 gM ACPD 
C  100 gM ACPD  ~Ill~~ 
1 mM L-AP3 
20 s 
FIGURE 4.  Effects  of L-AP4 and the mGluR antagonists,  L-AP3 and 4C3H-PG, on responses 
to 1SR,3RS-ACPD. (A) L-AP4 (5 o,M) was applied for 40 s before applying 1SR,3RS-ACPD (100 
o,M). At  the  holding  potential  of -50  mV,  L-AP4  evoked  an  outward  current  which  was 
unchanged by the concurrent application of ISR,3RS-ACPD. The responses illustrated in A-C 
are all from the same cell.  (B) Following washout of L-AP4 from the bath, the application of 
1SR,3RS-ACPD evoked an outward current. (C) The ACPD receptor antagonist, L-AP3 (1 mM), 
was applied for 70 s before beginning  1SR,3RS-ACPD  (100  o,M). The response to  1SR,3RS- 
ACPD was almost identical to that in B and therefore appeared to be unaffected by L-AP3. (D) 
ISR,3RS-ACPD (200 o,M) evoked an outward current which was not appreciably reduced by the 
application  of either  L-AP3  (1  mM)  or  4C3H-PG  (0.5  mM).  The  rapid  inward  transient 
observed after the application of 4C3H-PG had a much faster time course than the responses to 
bath applied drugs and was probably an artifact. (E) Another trial from a different ON bipolar 
cell showing that the outward current evoked by 1SR,3RS-ACPD (200 0,M) was not detectably 
reduced by the application of 4C3H-PG (0.5 mM). 
binding site or of some subsequent process, such as the closure of cation channels. In 
the  presence  of L-AP4,  ISR,3RS-ACPD  (100  IxM)  failed  to  induce  any  detectable, 
additional  current.  Following  recovery  from  L-AP4,  1SR,3RS-ACPD  evoked  an 
outward current of 35 pA (Fig. 4  B). Similar results were obtained in four cells. The 
ability of L-AP4 to occlude the ACPD current  strongly indicates  that at  some point 
along the pathway, either at the receptor level or subsequent cascade of events, both 
ACPD and  AP4  activate  the  same  post-synaptic  mechanism.  There  is  currently  no THORESON AND MILLER  1S,3R-ACPD Is an Agonist at Retinal L-AP4 Receptors  1027 
known  antagonist  to  L-AP4 receptors  (Koerner and Johnson,  1992)  so  it was  not 
possible to test the effects of an L-AP4 antagonist. 
L-2-amino-3-phosphonopropionic acid  (L-AP3) is  an antagonist  at some mGluRs 
(Schoepp, Johnson,  Smith,  and  McQuaid,  1990b;  Sahara  and  Westbrook,  1993; 
Schoepp and Conn,  1993). Fig. 4 C illustrates responses evoked by  1SR,3RS-ACPD 
(100 IxM) and L-AP3 (1 raM) in the same cell as the responses illustrated in Fig. 4, A 
and B. Application of L-AP3 alone evoked no response.  In the presence of L-AP3, 
1SR,3RS-ACPD  evoked an  outward  current of 35  pA,  the  same  amplitude  as  the 
earlier  control  response  shown  in  Fig.  4 B.  The  responses  to  1SR,3RS-ACPD  in 
L-AP3 averaged 17.8 -+ 4.9 pA whereas the control responses to ACPD in these trials 
averaged  17.3  +  5.0  pA  (n--4).  This  indicates  that  L-AP3  failed  to  antagonize 
significantly the responses to ACPD in ON bipolar cells. 
Because of the washout of responses to L-AP4 and ACPD (Figs. 2 and 3), assessing 
the degree of antagonism by comparing the amplitudes of control and test responses 
is problematic. Therefore the possible antagonism of L-AP3 was also tested applying 
L-AP3 in the presence of ISR,3RS-ACPD. As shown in Fig. 4 D,  the outward current 
evoked by  1SR,3RS-ACPD  (200  p.M) appeared  to be unaffected by L-AP3 (1  mM) 
indicating  that  L-AP3  does  not  block  the  effects of ACPD  in  this  cell.  A  similar 
absence  of antagonism  was  seen  in  all  three  ON  bipolar  cells  tested  with  this 
paradigm. 
Electrophysiological responses to  1S,3R-ACPD, but not PI hydrolysis, are antago- 
nized  by  4-carboxy-3-hydroxyphenylglycine (4C3H-PG)  in  the  spinal  cord  and 
thalamus  (Jones,  Porter,  Birse,  Pook,  Sunter,  Udvarhelyi, Wharton,  Roberts,  and 
Watkins,  1992;  Eaton, Salt,  Udvarhelyi, Wharton,  and Watkins,  1992). As  shown in 
both Fig. 4, D and E, application of 4C3H-PG (0.5 mM) did not appear to antagonize 
the responses to 1SR,3RS-ACPD (20 IxM) in retinal ON bipolar cells (n =  5). A rapid 
inward  transient was  observed  after application  of 4C3H-PG  in  Fig.  4 D  but  this 
transient is much more rapid than the slow changes induced by bath application so it 
probably does not reflect antagonism by 4C3H-PG. A similar inward transient was not 
observed in other trials with 4C3H-PG (e.g., Fig. 4 E).  In addition to its absence of 
antagonism  to  ISR,3RS-ACPD,  4C3H-PG  (0.5  raM)  failed  to  block  responses  to 
L-AP4 (5  p,M) (data not shown, n  =  5),  indicating that it is not an L-AP4 receptor 
antagonist. 
The  results  of Fig.  4  suggest  that  4C3H-PG  is  not  an  antagonist  to ACPD  (or 
L-AP4) in ON bipolar cells. Instead, as shown in Fig. 5, 4C3H-PG appears to be an 
agonist  in  ON  bipolar  cells.  Like  L-AP4,  4C3H-PG  (1  mM)  evoked  an  outward 
current  accompanied  by  a  decrease  in  membrane  noise  (Fig.  5 A).  This  outward 
current reversed at  + 10 mV and was accompanied by a conductance decrease (Fig. 
5 B). 4C3H-PG (0.5-1.0 raM) evoked an outward current and conductance decrease 
in three of four cells tested. These results suggest that, like 1S,3R and  1S,3S-ACPD, 
4C3H-PG is also an agonist at L-AP4 receptors. 
The  results  described  above  strongly  suggest  that  the  ionic  current  evoked  by 
1S,3R-ACPD in mudpuppy ON bipolar cells is generated by the activation of L-AP4 
receptors.  This  supports  other findings  that  the  only glutamate  receptors  in  ON 
bipolar  cells  of urodele  amphibians  are  L-AP4  receptors  (Nawy  and Jahr,  1991; 
Thoreson and Miller,  1993). 1028  THE  JOURNAL OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  103  ￿9 1994 
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FIGURE 5.  (A) Membrane current of 
an ON bipolar cell in response to the 
mGluR antagonist, 4C3H-PG (1 mM). 
The vertical transients are due to 150 
ms  voltage  steps  used  to  determine 
the cell's current/voltage relationship 
in the presence of the drug. (B) Cur- 
rent/voltage  relationship  calculated 
by  subtracting  the  control  current/ 
voltage  relationship  from  that  ob- 
tained  in the presence of the 4C3H- 
PG. 
ERG Pharmacology 
Taking  advantage  of the  absence  of other  glutamate  receptors  in  mudpuppy  ON 
bipolar cells, we examined the sensitivity of L-AP4 receptors to the four enantiomers 
of ACPD. The washout of L-AP4 and ACPD responses prevented  the  acquisition  of 
reliable  concentration/response  curves using  the whole cell patch clamp  technique. 
However,  the  b-wave  of the  ERG  reflects  the  activity  of ON  bipolar  cells  in  the 
mudpuppy,and  can  be  used  as an  assay for L-AP4 receptor  activity  (Stockton and 
Slaughter,  1989;  Peterson  et  al.,  1991).  1S,3R-ACPD  is  not  taken  up  by  plasma 
membrane glutamate uptake (Winter and Ueda,  1993), so the superfused concentra- 
tion  of the ACPD enantiomers  is  presumably  the  concentration which reached  the 
cells. 
Fig. 6 shows examples of ERGs recorded in a mudpuppy retina in control Ringer's 
solution and in the presence of 1S,3R-ACPD (80 ~M). The control and test responses 
are superimposed. The b-wave was measured from the peak of the a-wave to the peak 
of the b-wave. The fractional  response  of the  ERG b-wave was calculated  from  the 
• B-wave  1  s 
FIGURE 6.  DC  intraretinal  electro- 
retinogram  (ERG)  from  the  mud- 
puppy retina.  Recording pipette was 
placed just proximal to the outer lim- 
iting membrane. The ERGs in control 
Ringer's solution and in the presence 
of IS,3R-ACPD (80 p,M) are superim- 
posed.  The  peaks  of the  a-  and  b- 
waves  are noted in the control ERG. 
The  amplitude  of  the  b-wave  was 
measured  from  the  peak  of the  a-wave  to  the  peak  of the  b-wave.  In  this  example,  the 
amplitude of the control b-wave was  1,558 pN while  the b-wave in the presence of ACPD was 
942 ~.V, yielding a fractional response in the presence of ACPD of 0.60. Note that 1S,3R-ACPD 
selectively  attenuated the b-wave without affecting the a-wave. THORESON AND MILLER  IS,3R-ACPD Is an Agonist at Retinal L-AP4 Receptors  1029 
ratio of the amplitude of the b-wave in the presence of the drug to the amplitude in 
control Ringer's. Note that  1S,3R-ACPD  suppresses the b-wave without suppressing 
the a-wave. 
Fig.  7  shows the mean fractional response of the ERG b-wave as a  function of log 
concentration of 1S,3R-ACPD (open circles) and 1S,3S-ACPD (filled circles). The results 
show that  1S,3R-ACPD is 4.7  times more potent than  1S,3S-ACPD. The  1R isomers 
had little effect on L-AP4 receptors (data not shown). At a  concentration  of 5  raM, 
1R,3S-ACPD suppressed the b-wave by 20% (n =  3), but this degree of suppression 
can be accounted  for by the  contamination  of 1R,3S-ACPD  by  ~  1%  IS,3R-ACPD 
(Sunter,  Edgar,  Pook,  Howard,  Udvarhelyi,  and Watkins,  1991).  1R,3R-ACPD  (3.2 
raM, n  =  1; 5 mM, n  =  2) did not suppress the b-wave. 
As  described  in  the  Methods,  IC~0's  were  determined  by  fitting  a  theoretical 
binding curve to the data (Fig.  7, solid lines). The  rank order potency and ICs0's for 
L-AP4 (Peterson et al.,  1991) and the ACPD stereoisomers are: L-AP4 (1.1  wM)  >> 
1S,3R-ACPD (89 oLM) >  1S,3S-ACPD (417  oLM) >>  1R,3S-ACPD;  1R,3R-ACPD (>5 
raM). 
1.0 
0.8" 
0 
o61 
~  0.4" 
o 
0.2" 
0.0 
........  ,  ........ ,  ........ ,  .  ..  ~...... 
10  1  O0  1000  10000 
Concentration  (izM) 
FIGURE 7.  Concentration/response 
relationships  for  IS,3R-ACPD  (open 
circles) and  IS,3R-ACPD (filled circles) 
at  L-AP4 receptors.  The  mean  frac- 
tional  response  of the  ERG  b-wave 
(b/b~,) is plotted as a function of log 
agonist concentration. Each curve was 
repeated  four  times.  Error  bars  = 
_+SEM. The data were fit by a  theo- 
retical  binding  equation  where  the 
ICs0 and Hill coefficient  (h) were al- 
lowed  to  vary  (see  Methods).  For 
IS,3R-ACPD,  ICs0  =  89  IxM, h  = 
2.06;  for  IS,3S-ACPD,  ICs0 =  417 
~M, h  =  2.15. 
DISCUSSION 
The results of this  study reveal a  consistent  similarity between the effects of L-AP4 
and the mGluR agonist,  1S,3R-ACPD, in mudpuppy ON bipolar cells. (a) Both drugs 
evoked identical currents which indicates that they close the same ion channels (Fig. 
1). This is consistent with a recent abstract which reported that 1S,3R-ACPD and the 
endogenous photoreceptor transmitter produce similar currents in ON bipolar cells 
(Slaughter and Tian,  1993).  (b) The responses to both drugs washed out in parallel 
(Fig.  2).  The  parallel  washout  suggests  that  both  drugs  act  through  the  same 
intracellular  second  messenger  pathway.  (c)  The  rate  of washout  of responses  to 
L-AP4  and  1SR,3RS-ACPD  were  both  increased  by  the  cGMP-PDE  inhibitors, 
zaprinast  or  dipyridamole,  suggesting  that  both  L-AP4  and  1S,3R-ACPD  activate 
cGMP-PDE (Fig. 3). (d) Prior activation of L-AP4 receptors occluded the response to 1030  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  103  ￿9  1994 
1SR,3RS-ACPD,  whereas  the  non-AP4,  mGluR  antagonists,  L-AP3  and  4C3H-PG, 
had no effect on responses to ACPD (Fig. 4). These results indicate that 1S,3R-ACPD 
is an agonist at L-AP4 receptors in retinal ON bipolar cells of the mudpuppy. 
One could argue that a more direct way to test whether both ACPD and L-AP4 act 
at the same receptors would be to determine if they occupy the same binding sites 
using  radioligand  binding  assays.  However,  the  binding  of ~H-L-AP4  or  L-AP4 
displaceable  3H-glutamate  is  pharmacologically distinguishable  from  electrophysi- 
ologically defined L-AP4 receptors suggesting that the binding site is not the L-AP4 
receptor recognition site (Fagg and Lanthorn, 1985; Crooks, Robinson, Koerner, and 
Johnson, 1986). Therefore, binding studies would not provide an unequivocal answer 
to  the  question  of whether  these  two  compounds  act  at  the  same  or  different 
receptors. 
In  addition  to  showing  that  1S,3R-ACPD  is  an  agonist  at  L-AP4 receptors,  the 
results  of  this  study  indicate  that  L-AP4  receptors  are  the  only  metabotropic 
glutamate receptors in mudpuppy ON bipolar cells. This finding is consistent with 
other electrophysiological studies which  suggest that  L-AP4 receptors are  the  only 
glutamate  receptors  in  ON  bipolar  cells  of urodele  amphibians  (Nawy  and Jahr, 
1991;  Thoreson  and  Miller,  1993)  and  with  in  situ  hybridization  experiments 
indicating  that  mGluRI-4  expression  is  limited  to  amacrine  and  ganglion  cells 
(Tanabe-Ohuchi, Yoshimura, Shigemoto, and Honda,  1992). 
The absence of other glutamate receptor types in ON bipolar cells made it possible 
to determine concentration/response relationships for the four enantiomers of ACPD 
acting  at  L-AP4  receptors  relatively  uncontaminated  by  their  effects  at  other 
glutamate  receptors.  Knowledge  of the  rank-order  potency of mGluR agonists  at 
retinal L-AP4 receptors in vivo is important for confirming that a  cloned receptor, 
e.g., mGluR6, is the retinal L-AP4 receptor. 
The responses of ON bipolar cells are reflected in the b-wave of the ERG (Stockton 
and  Slaughter,  1989)  and  the  b-wave  was  used  as  an  assay  of ON  bipolar  cell 
responses. To assess the correspondence of rank-order potencies obtained using the 
ERG with the potencies observed with whole cell recordings, we compared response 
ratios  obtained  using  whole  cell  recording  techniques  with  the  response  ratios 
determined from concentration/response curves for ACPD enantiomers (Fig. 7) and 
L-AP4 (Peterson et al.,  1991). From concentration/response curves, the responses to 
80 and  160 ~M  IS,3R-ACPD and 640 txM  1S,3S-ACPD should be 57, 78, and 72%, 
respectively, of the response to 5 IxM L-AP4. The whole cell currents evoked by these 
compounds were 56% (n =  2),  110%  (n =  3),  and  82%  (n =  4), respectively, of the 
currents evoked by L-AP4 in the same cells. Given the difficulty in obtaining reliable 
concentration/response data from whole cell recordings due to the washout of whole 
cell  currents  (Figs.  2  and  3),  these  ratios  agree  reasonably  well  with  the  ratios 
predicted from the concentration/response curves obtained using the ERG. 
The rank-order potency of ACPD enantiomers at retinal L-AP4 receptors appears 
similar to their rank-order potency at non-AP4, mGluRs in brain. Both retinal L-AP4 
receptors and brain mGluRs exhibit a strong stereospecificity, preferring IS isomers 
over 1R isomers (Schoepp et al.,  1991b).  Given this  stereospecificity, the effects of 
racemic  1SR,3RS-  and  1SR,3SR-ACPD  at mGluRs  in brain  are  probably mediated 
largely by the  1S,3R-  and  1S,3S-enantiomers,  respectively. Therefore, the  finding THORESON AND MILLER  1S,3R-ACPD Is an Agonist at Retinal L-AP4 Receptors  1031 
that in hippocampus and cerebral cortex 1SR,3RS-ACPD is 3.2 and 4.1  times more 
potent, respectively, than  ISR,3SR-ACPD in stimulating IP3 production (Schoepp et 
al., 1991a) correlates well with the present finding that 1S,3R-ACPD is 4.7 times more 
potent than  1S,3S-ACPD.  The common preference of 1S  over  1R isomers and  of 
1S,3R over 1S,3S  suggests that there is some similarity between the binding sites of 
retinal L-AP4 receptors and brain, non-AP4 mGluRs. Two other characteristic mGluR 
agonists,  ibotenate  and  quisqualate,  also  appear  to  be  agonists  at  retinal  L-AP4 
receptors (Slaughter and Miller, 1985). These similarities between the pharmacology 
of L-AP4 receptors and non-AP4, mGluRs support the hypothesis that 1S,3R-ACPD is 
an agonist at all metabotropic glutamate receptors whereas L-AP4 activates a limited 
subset of this receptor class (Thomsen et al.,  1992; Nakanishi,  1992; Tanabe et al., 
1993). None of the mGluR agonists thus far tested are selective for non-AP4 over AP4 
mGluRs. 
There are currently no known L-AP4 receptor antagonists (Koerner and Johnson, 
1992).  The  similarity between  the  binding  sites  of L-AP4 receptors  and  non-AP4 
mGluRs  raises  the  possibility  that  non-AP4,  mGluR  antagonists  may  also  act  as 
antagonists at L-AP4 receptors. Three putative mGluR antagonists were examined in 
the present study, but none of them are L-AP4 antagonists.  In some preparations, 
L-AP4 can act as a weak mGluR antagonist (Nicoletti, Meek, Iadarola, Chuang, Roth, 
and  Costa,  1988;  Schoepp  and Johnson,  1988).  The  present  results  suggest  that 
another mGluR antagonist, 4C3H-PG, is also an L-AP4 receptor agonist (Fig. 5). A 
third  mGluR  antagonist,  L-AP3,  does  not  appear  to  be  either  an  agonist  or 
antagonist  at  L-AP4  receptors  (Fig.  4;  Slaughter  and  Miller,  1985).  It will  be  of 
interest to see if any future mGluR antagonists prove to be L-AP4 antagonists. 
1S,3R-ACPD  is  selective for mGluRs  over ionotropic glutamate  receptors and  is 
therefore useful for demonstrating  the  presence of mGluRs.  However, the present 
results  indicate  that  it  is  not useful  for discriminating  between AP4  and  non-AP4 
mGluRs.  Discriminating  between  these  mGluR subtypes requires  the  use  of other 
compounds, such as L-AP4. 
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